Merck nears $1.3 bln takeover of Eyebiotech- WSJ

  • Investing.com
  • Stock Market News
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Credit: © Reuters.

Investing.com-- Merck & Company Inc (NYSE: MRK ) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday. 

The drugmaker is expected to pay $1.3 billion in cash for the ophthalmology firm, and could pay up to $1.7 billion in additional milestone payments, the WSJ reported, citing people with knowledge of the matter. 

 

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles